)

Iteos Therapeutics (ITOS) investor relations material
Iteos Therapeutics Q2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Executive summary
Announced wind-down of clinical and operational activities following termination of lead program and GSK collaboration; merger with Concentra Biosciences pending, with expected completion in Q3 2025.
Lead antibody candidate belrestotug program discontinued after failing to meet key clinical endpoints; all related trials and collaboration with GSK ended.
EOS-984 and EOS-215 programs remain as assets for potential disposition under the merger's contingent value rights (CVRs).
Substantial doubt exists about ability to continue as a going concern absent completion of the merger or alternative transaction.
Financial highlights
No revenue recognized in Q2 2025; $35.0M license and collaboration revenue recognized in Q2 2024 from GSK milestone.
Net loss of $78.7M for Q2 2025, compared to $7.1M in Q2 2024; net loss of $113.3M for six months ended June 30, 2025, up from $45.3M year-over-year.
Research and development expenses rose to $57.3M in Q2 2025 from $36.7M in Q2 2024, mainly due to GSK termination payment.
Restructuring costs of $16.3M recorded in Q2 2025 related to severance and wind-down.
Cash and cash equivalents of $207.8M and available-for-sale securities of $382.2M as of June 30, 2025.
Outlook and guidance
Merger with Concentra expected to close in Q3 2025, subject to conditions including minimum $475M net cash at closing.
If merger is not completed, company may pursue alternative strategic transaction or dissolution and liquidation.
No plans to resume R&D if merger fails; wind-down of operations expected to be substantially complete in Q3 2025.
Next Iteos Therapeutics earnings date

Next Iteos Therapeutics earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage